News Archive

2020

November

Media Release / Nov 05, 2020

Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study

Read More

October

Media Release / Oct 05, 2020

Novartis STEP Program™ awards nearly $375,000 to patient advocacy organizations for their innovative solutions in biomarker testing; now accepting proposals for caregiving in cancer and certain blood disorders

Read More
Media Release / Oct 03, 2020

Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine

Read More

September

Media Release / Sep 16, 2020

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US

Read More
Media Release / Sep 11, 2020

Novartis presents data at ACTRIMS-ECTRIMS on the effects of treatment with Mayzent® (siponimod) studied on disability progression and cognitive processing speed in patients with progressing relapsing multiple sclerosis

Read More
Media Release / Sep 11, 2020

Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis

Read More

August

Media Release / Aug 30, 2020

Novartis PARALLAX data provides further evidence of the potential benefit of Entresto® in patients with HFpEF

Read More
Media Release / Aug 30, 2020

Novartis new analysis shows high consistency in lowering LDL-C in individual response with investigational inclisiran

Read More
Media Release / Aug 27, 2020

Novartis launches PsO in the Know podcast series hosted by music icon Cyndi Lauper

Read More
Media Release / Aug 20, 2020

FDA approves Novartis Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis

Read More

Related Links